Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Walliser

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Oncotarget|October 23, 2018
Functional characterization of phospholipase C-γ<sub>2</sub> mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorderClaudia Walliser, Martin Wist, Elisabeth Hermkes, et al.
The Journal of Biological Chemistry|March 19, 2020
Noncatalytic Bruton's tyrosine kinase activates PLCγ<sub>2</sub> variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cellsMartin Wist, Laura Meier, Orit Gutman, et al.
Molecular Cell|April 28, 2009
Structural insights into formation of an active signaling complex between Rac and phospholipase C gamma 2Tom D Bunney, Olaniyi Opaleye, S Mark Roe, et al.
Molecular and Cellular Biology|January 20, 2011
Membrane environment exerts an important influence on rac-mediated activation of phospholipase Cγ2Katy L Everett, Anja Buehler, Tom D Bunney, et al.
Blood|October 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Oncotarget|October 23, 2018
Functional characterization of phospholipase C-γ<sub>2</sub> mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorderClaudia Walliser, Martin Wist, Elisabeth Hermkes, et al.
The Journal of Biological Chemistry|March 19, 2020
Noncatalytic Bruton's tyrosine kinase activates PLCγ<sub>2</sub> variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cellsMartin Wist, Laura Meier, Orit Gutman, et al.
Molecular Cell|April 28, 2009
Structural insights into formation of an active signaling complex between Rac and phospholipase C gamma 2Tom D Bunney, Olaniyi Opaleye, S Mark Roe, et al.
Molecular and Cellular Biology|January 20, 2011
Membrane environment exerts an important influence on rac-mediated activation of phospholipase Cγ2Katy L Everett, Anja Buehler, Tom D Bunney, et al.
Blood|October 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, et al.
Pageof 2